NASDAQ:MGTX
MeiraGTx Holdings Plc Stock News
$5.00
+0.0100 (+0.200%)
At Close: May 03, 2024
MeiraGTx Announces Pricing of Public Offering of Ordinary Shares
07:00am, Thursday, 19'th Nov 2020
LONDON and NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq:MGTX), a vertically integrated, clinical stage gene therapy company, today announced the pricing of an underwrit
MeiraGTx Announces Proposed Public Offering of Ordinary Shares
04:25pm, Wednesday, 18'th Nov 2020
LONDON and NEW YORK, Nov. 18, 2020 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that it has commenced an un
Data presented at AAO 2020 Virtual Annual Meeting show sustained improvements in retinal sensitivity at 12 months Data presented at AAO 2020 Virtual Annual Meeting show sustained improvements in retin
MeiraGTx to Present at the Barclays Gene Editing & Gene Therapy Summit
04:30pm, Tuesday, 10'th Nov 2020
LONDON and NEW YORK, Nov. 10, 2020 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes,
MeiraGTx Reports Third Quarter 2020 Financial Results
08:30am, Thursday, 05'th Nov 2020
LONDON and NEW YORK,, Nov. 05, 2020 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced financial results for the
12-Month Dose Escalation Data from Phase 1/2 Clinical Trial to be Presented 12-Month Dose Escalation Data from Phase 1/2 Clinical Trial to be Presented
MeiraGTx Is A Buy With Multiple Near-Term Catalysts As The Stock Is Weighed Down By Negative Sentiment
02:51pm, Monday, 24'th Aug 2020
MGTX share price has failed to recover to pre-COVID-19 levels despite promising developments. MGTX partnership with Janssen on several lead indications.
Did Hedge Funds Make The Right Call On MeiraGTx Holdings plc (MGTX) ?
01:42pm, Wednesday, 12'th Aug 2020
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail invest
MeiraGTx Reports Second Quarter 2020 Financial Results
12:00pm, Thursday, 06'th Aug 2020
\- Positive initial data from Phase 1/2 clinical trial of AAV-RPGR for the treatment of XLRP recently presented \- AAV-RPGR to advance into Phase 3 Lumeos clinical trial \- Expands manufacturing cap
MeiraGTx Expands Leadership Team with Appointment of Robert K. Zeldin, M.D. as Chief Medical Officer
12:30pm, Wednesday, 05'th Aug 2020
LONDON and NEW YORK, Aug. 05, 2020 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced the appointment of Robert
MeiraGTx Sees Hammer Chart Pattern: Time to Buy?
12:18pm, Monday, 27'th Jul 2020
MeiraGTx has been struggling lately, but the selling pressure may be coming to an end soon.
MeiraGTx Positive Data, And Other News: The Good, Bad And Ugly Of Biopharma
06:38pm, Monday, 20'th Jul 2020
MeiraGTx reports encouraging data for ocular gene therapy. Eli Lilly posts positive update for Mirikizumab.
Do Insiders Own Lots Of Shares In MeiraGTx Holdings plc (NASDAQ:MGTX)?
12:45pm, Friday, 17'th Jul 2020
Every investor in MeiraGTx Holdings plc (NASDAQ:MGTX) should be aware of the most powerful shareholder groups...
• Data being presented at the American Society of Retina Specialists (ASRS) 2020 Virtual Annual Meeting • Significant improvements demonstrated after treatment in Phase 1/2.
MeiraGTx Holdings PLC (MGTX) Moves to Strong Buy: Rationale Behind the Upgrade
04:00pm, Friday, 26'th Jun 2020
MeiraGTx Holdings PLC (MGTX) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
